Tropicamide and Myopia Progression

Ophthalmology

Volumn 115, Issue 6, 2008, Pages 1103-1104

  Iribarren, Rafael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; PIRENZEPINE; PLACEBO; TROPICAMIDE;

ACCOMMODATION PARALYSIS; CLINICAL TRIAL; DISEASE COURSE; DRUG MECHANISM; EVENING DOSAGE; FOLLOW UP; HUMAN; LETTER; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PUPIL DISEASE; REFRACTION ERROR; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ASTIGMATISM; ATROPINE; DISEASE PROGRESSION; HUMANS; MUSCARINIC ANTAGONISTS; MYOPIA; OPHTHALMIC SOLUTIONS; REFRACTION, OCULAR; TROPICAMIDE;

EID: 44349151422     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.11.018     Document Type: Letter

References (6)

1. Chua W.H., Balakrishnan V., Chan Y.H., et al. Atropine for the treatment of childhood myopia. Ophthalmology 113 (2006) 2285-2291
2. Luft W.A., Ming Y., and Stell W.K. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest Ophthalmol Vis Sci 44 (2003) 1330-1338
3. Tan D.T., Lam D.S., Chua W.H., et al. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology 112 (2005) 84-91
4. Siatkowski R.M., Cotter S., Miller J.M., et al. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study. Arch Ophthalmol 122 (2004) 1667-1674
5. Abraham S.V. Control of myopia with tropicamide: a progress report. J Pediatr Ophthalmol 3 (1966) 10-22
6. Saw S.M., Gazzard G., Au Eong K.G., and Tan D.T. Myopia: attempts to arrest progression. Br J Ophthalmol 86 (2002) 1306-1311